Octopus Biosafety SA (EPA:MLOCT)
France flag France · Delayed Price · Currency is EUR
0.1390
0.00 (0.00%)
Aug 19, 2026, 11:30 AM CET

Octopus Biosafety Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.390.390.660.280.540.66
Revenue Growth
-41.80%-41.27%136.30%-48.32%-18.85%5013.35%
Gross Profit
-0.34-0.34-0.07-0.060.05-0.2
Operating Income
-0.84-0.84-1.44-0.73-1.12-1.4
Net Income
-0.66-0.66-1.78-0.8-1.01-0.83
Earnings Per Share
-0.04-0.04-0.12-0.20-0.25-0.21
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2024
Period EndingDec '24 Dec '24
France
0.050.05
Export
00
Unallocated
0.330.33
Total
0.390.39

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.020.020.130.060.080.69
Total Debt
0.550.550.352.71.720.47
Net Cash (Debt)
-0.52-0.52-0.23-2.64-1.650.22
Net Cash Growth
------
Net Cash Per Share
-0.03-0.03-0.02-0.65-0.410.06

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-87.32%-87.32%-10.67%-19.87%10.21%-30.05%
Operating Margin
-217.46%-217.46%-219.33%-261.62%-208.59%-211.76%
Pretax Margin
-225.43%-225.43%-300.17%-345.80%-234.11%-160.54%
Profit Margin
-171.15%-171.15%-271.02%-289.29%-188.21%-125.74%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
45.887.104.746.115.948.82